ticarcillin has been researched along with sulbactam in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (14.63) | 18.7374 |
1990's | 19 (46.34) | 18.2507 |
2000's | 12 (29.27) | 29.6817 |
2010's | 4 (9.76) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arlet, G; Loli, A; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
Hawley, JS; Jorgensen, JH; Murray, CK | 1 |
Courvalin, P; Decré, D; Høiby, EA; Meziane-Cherif, D; Périchon, B | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Arpin, C; Bezian, MC; Coulange, L; Demarthe, F; Dubois, V; Minarini, LA; Nordmann, P; Poirel, L; Quentin, C | 1 |
Chanteperdrix, V; Croizé, J; Nordmann, P; Poirel, L; Potron, A | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
De Luca, F; Docquier, JD; Ide, L; Nordmann, P; Poirel, L; Rossolini, GM; Verlinde, A | 1 |
Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Girlich, D; Nordmann, P; Poirel, L | 1 |
Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS | 1 |
Bawdon, RE; Dax, JB; Gilstrap, LC; Maberry, MC; Sobhi, S; Trimmer, KJ | 1 |
Danziger, LH; Itokazu, GS | 1 |
Ayers, OM; Everett, BQ; Hill, GB | 1 |
Acar, JF; Denis, F; Drugeon, H; Fleurette, J; Kazmierczak, A; Siebor, E; Sirot, J; Soussy, CJ; Thabaut, A | 1 |
Cavalieri, SJ; New, C; Sanders, CC | 1 |
Pastorek, JG | 1 |
Sutherland, R | 1 |
Aldridge, KE; Sanders, CV | 1 |
Barry, AL; Fuchs, PC | 1 |
Sanders, CC; Sanders, WE; Thomson, KS; Weber, DA | 1 |
Appelbaum, PC; Aronoff, SC; Jacobs, MR; Yamabe, S | 1 |
Acar, JF; Coutrot, A; Ferré, B; Gutmann, L; Kitzis, MD | 1 |
Barry, AL; Jones, RN; Packer, RR | 1 |
Aronoff, SC; Jacobs, MR; Johenning, S; Yamabe, S | 1 |
Eggleston, M; Parker, RH | 1 |
Ito, T; Tamura, M | 1 |
Burnham, LB; Citron, DM; Goldstein, EJ; Inderlied, CB; Kenner, MA | 1 |
Appelbaum, PC; Jacobs, MR; Pankuch, GA | 1 |
Manzella, JP | 1 |
Miller, LA; Poupard, JA; Rittenhouse, SF; Utrup, LJ | 1 |
Klepser, ME; Marangos, MN; Nicolau, DP; Nightingale, CH; Quintiliani, R; Zhu, Z | 1 |
Hanaki, H; Nagayama, A; Nomura, S | 1 |
Arndt, PA; Garratty, G | 1 |
Betriu, C; Gómez, M; Palau, ML; Picazo, JJ; Sánchez, A | 1 |
McKinnon, PS; Neuhauser, MM | 1 |
Miranda, E; Sader, HS; Sejas, L; Tosin, I | 1 |
Powell, LL; Wilson, SE | 1 |
Olweny, J; Stucki, ZN; Torbert, DP; WaKabongo, M | 1 |
Das, BK; Dhawan, B; Kapil, A; Mohanty, S; Singhal, R; Sood, S | 1 |
5 review(s) available for ticarcillin and sulbactam
Article | Year |
---|---|
Ampicillin-sulbactam and ticarcillin-clavulanic acid: a comparison of their in vitro activity and review of their clinical efficacy.
Topics: Ampicillin; Arthritis, Infectious; Bacterial Infections; Bacteroides fragilis; beta-Lactamase Inhibitors; Clavulanic Acids; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Osteomyelitis; Pelvic Inflammatory Disease; Respiratory Tract Infections; Sulbactam; Ticarcillin | 1991 |
Antibiotic therapy for pelvic inflammatory disease.
Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; Chlamydia Infections; Chlamydia trachomatis; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Gonorrhea; Humans; Pelvic Inflammatory Disease; Sulbactam; Ticarcillin | 1990 |
Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Kinetics; Penicillanic Acid; Penicillin Resistance; Penicillins; Sulbactam; Ticarcillin | 1987 |
[Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors].
Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Penicillanic Acid; Penicillins; Respiratory Tract Infections; Sulbactam; Ticarcillin | 1987 |
The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection.
Topics: Abdomen; Abdominal Abscess; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Surgical Wound Infection; Ticarcillin | 2000 |
2 trial(s) available for ticarcillin and sulbactam
Article | Year |
---|---|
[In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study].
Topics: Acinetobacter; Cefoperazone; Cefotaxime; Ceftazidime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterobacteriaceae; Humans; In Vitro Techniques; Mezlocillin; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Ticarcillin | 1991 |
Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa.
Topics: Adult; Ampicillin; Bacteroides fragilis; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Cross-Over Studies; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Female; Humans; Male; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Serum Bactericidal Test; Sulbactam; Tazobactam; Ticarcillin | 1997 |
34 other study(ies) available for ticarcillin and sulbactam
Article | Year |
---|---|
SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillinase; Plasmids; Sequence Analysis, DNA | 2007 |
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Aged; Anti-Bacterial Agents; Bacteremia; Calcaneus; Colistin; Humans; Male; Microbial Sensitivity Tests; Osteomyelitis | 2007 |
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
Topics: Amino Acid Sequence; beta-Lactams; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillinase; Sequence Alignment; Sequence Analysis, DNA; Substrate Specificity | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.
Topics: Aged; Amino Acid Substitution; Base Sequence; beta-Lactam Resistance; beta-Lactamases; DNA Primers; DNA, Bacterial; Female; Genes, Bacterial; Humans; Isoelectric Point; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Mutagenesis, Insertional; Recombinant Proteins | 2008 |
Genetic and biochemical characterization of the first extended-spectrum CARB-type beta-lactamase, RTG-4, from Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
Topics: Belgium; beta-Lactamases; Cephalosporinase; Cephalosporins; Cross Infection; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2010 |
PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila.
Topics: Aeromonas; Animals; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Paris; Water Microbiology | 2010 |
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
Topics: Ampicillin; beta-Lactamases; Computational Biology; Escherichia coli; Hydrogen Bonding; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Protein Structure, Secondary; Ticarcillin | 2010 |
Antibiotic concentration in maternal blood, cord blood and placental tissue in women with chorioamnionitis.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefotaxime; Chorioamnionitis; Chromatography, High Pressure Liquid; Clavulanic Acid; Clavulanic Acids; Female; Fetal Blood; Humans; Placenta; Pregnancy; Regression Analysis; Sulbactam; Ticarcillin | 1992 |
Susceptibilities of anaerobic gram-negative bacilli to thirteen antimicrobials and beta-lactamase inhibitor combinations.
Topics: Ampicillin; Anti-Bacterial Agents; Antiprotozoal Agents; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Anaerobic Bacteria; Microbial Sensitivity Tests; Sulbactam; Ticarcillin | 1991 |
Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymes.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Enzyme Induction; Mice; Microbial Sensitivity Tests; Sulbactam; Ticarcillin | 1991 |
Development of beta-lactamase inhibitors.
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Drugs, Investigational; Humans; Penicillins; Sulbactam; Ticarcillin | 1990 |
In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
Topics: Ampicillin; Bacteria; Bacteroides fragilis; beta-Lactamase Inhibitors; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Clindamycin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillins; Sulbactam; Ticarcillin | 1990 |
Implications of beta-lactamase-inhibitor combinations.
Topics: Amoxicillin; Ampicillin; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Evaluation, Preclinical; Drug Therapy, Combination; Microbial Sensitivity Tests; Sulbactam; Ticarcillin | 1990 |
Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillins; Piperacillin; Sulbactam; Ticarcillin | 1990 |
In vitro activity of YTR 830.
Topics: Ampicillin; Bacteroides fragilis; beta-Lactamase Inhibitors; Clavulanic Acids; Drug Therapy, Combination; Enterobacteriaceae; Klebsiella; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Proteus vulgaris; Sulbactam; Tazobactam; Ticarcillin | 1989 |
In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Cephalosporinase; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Ticarcillin | 1989 |
In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.
Topics: Amoxicillin; Ampicillin; Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Penicillanic Acid; Penicillins; Sulbactam; Ticarcillin | 1986 |
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads.
Topics: Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Enterobacteriaceae; Mezlocillin; Naphthyridines; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas; Sulbactam; Ticarcillin | 1986 |
Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroidaceae; Child; Clarithromycin; Clavulanic Acid; Clavulanic Acids; Clostridium; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Sulbactam; Ticarcillin | 1995 |
Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Clavulanic Acids; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Piperacillin; Streptococcus pneumoniae; Sulbactam; Tazobactam; Ticarcillin | 1994 |
Parenteral beta-lactamase inhibitor combinations for clinical use.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Sulbactam; Ticarcillin | 1995 |
Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Enterobacter; Escherichia coli; Imipenem; Klebsiella pneumoniae; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Piperacillin; Proteus mirabilis; Pseudomonas aeruginosa; Quality Control; Reproducibility of Results; Sulbactam; Thienamycins; Ticarcillin | 1996 |
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Topics: Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam; Ticarcillin; Urinary Tract; Urinary Tract Infections | 1997 |
Positive direct antiglobulin tests and haemolytic anaemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic adsorption of protein onto red blood cells.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anemia, Hemolytic; Clavulanic Acids; Coombs Test; Drug Therapy, Combination; Enzyme Inhibitors; Erythrocytes; Female; Humans; Male; Middle Aged; Proteins; Sulbactam; Ticarcillin | 1998 |
In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoxitin; Ceftizoxime; Chloramphenicol; Clavulanic Acid; Clindamycin; Drug Therapy, Combination; Enzyme Inhibitors; Imipenem; Metronidazole; Mezlocillin; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Species Specificity; Sulbactam; Tazobactam; Thienamycins; Ticarcillin | 1999 |
Efficacy and cost of ampicillin-sulbactam and ticarcillin-clavulanate in the treatment of hospitalized patients with bacterial infections.
Topics: Adult; Aged; Ampicillin; Analysis of Variance; Bacterial Infections; Clavulanic Acids; Drug Costs; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Sulbactam; Ticarcillin; Treatment Outcome; United States | 1999 |
Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Clavulanic Acid; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam; Ticarcillin | 2000 |
Effect of bovine lactoferrin on the MICs of ampicillin/sulbactam (UNASYN), amoxicillin/clavulanic acid (Augmentin), ticarcillin clavulanate (Timentin), and piperacillin-tazobactam (ZOSYN), against clinical and environmental isolates of motile Aeromonas.
Topics: Aeromonas; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Clavulanic Acids; Lactoferrin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Ticarcillin | 2005 |
Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acids; Cross Infection; Gram-Negative Bacteria; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Ticarcillin | 2005 |